To investigate if variants of CHEK2 other than 1100delC confer an increased risk of breast cancer, we have screened a series of 68 familial breast cancer cases, which had been screened in the Regional Genetics Service and found to be negative for mutations in BRCA1 and BRCA2. This evidence concerns the gene CHEK2 and breast carcinoma.